BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Wang WL, Li Q, Qiao Q. Expression of transforming growth factor-α and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance. World J Gastroenterol 2004; 10(6): 830-833 [PMID: 15040026 DOI: 10.3748/wjg.v10.i6.830] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Chang P, Chi C, Chau G, Li F, Tsai Y, Wu J, Wu Lee Y. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 2006;25:1991-2003. [DOI: 10.1038/sj.onc.1209239] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 5.6] [Reference Citation Analysis]
2 Komposch K, Sibilia M. EGFR Signaling in Liver Diseases. Int J Mol Sci 2015;17:E30. [PMID: 26729094 DOI: 10.3390/ijms17010030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
3 Badawy AA, El-hindawi A, Hammam O, Moussa M, Gabal S, Said N. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis. APMIS 2015;123:823-31. [DOI: 10.1111/apm.12431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
4 Kim YJ, Kim HY, Kim JS, Lee JH, Yoon JH, Kim CY, Park BL, Cheong HS, Bae JS, Kim S, Shin HD, Lee HS. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Viral Hepat 2010;17:518-26. [PMID: 19780938 DOI: 10.1111/j.1365-2893.2009.01205.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
5 Yang ZF, Poon RT. Vascular changes in hepatocellular carcinoma. Anat Rec (Hoboken). 2008;291:721-734. [PMID: 18484619 DOI: 10.1002/ar.20668] [Cited by in Crossref: 112] [Cited by in F6Publishing: 112] [Article Influence: 8.0] [Reference Citation Analysis]
6 Liu XH, Pan MH, Lu ZF, Wu B, Rao Q, Zhou ZY, Zhou XJ. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis. 2008;40:560-567. [PMID: 18294932 DOI: 10.1016/j.dld.2007.12.011] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
7 Ayub A, Ashfaq UA, Haque A. HBV induced HCC: major risk factors from genetic to molecular level. Biomed Res Int. 2013;2013:810461. [PMID: 23991421 DOI: 10.1155/2013/810461] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
8 Alqahtani A, Khan Z, Alloghbi A, Said Ahmed TS, Ashraf M, Hammouda DM. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina (Kaunas) 2019;55:E526. [PMID: 31450841 DOI: 10.3390/medicina55090526] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
9 Breuhahn K, Longerich T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006;25:3787-800. [DOI: 10.1038/sj.onc.1209556] [Cited by in Crossref: 286] [Cited by in F6Publishing: 264] [Article Influence: 17.9] [Reference Citation Analysis]
10 Zaghloul RA, Elsherbiny NM, Kenawy HI, El-karef A, Eissa LA, El-shishtawy MM. Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. Life Sciences 2017;185:114-25. [DOI: 10.1016/j.lfs.2017.07.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
11 Hennig M, Yip-Schneider MT, Wentz S, Wu H, Hekmatyar SK, Klein P, Bansal N, Schmidt CM. Targeting mitogen-activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems. Hepatology 2010;51:1218-25. [PMID: 20112426 DOI: 10.1002/hep.23470] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
12 Geng M, Cao YC, Chen YJ, Jiang H, Bi LQ, Liu XH. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol 2012; 18(12): 1328-1338 [PMID: 22493546 DOI: 10.3748/wjg.v18.i12.1328] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
13 Jeng JE, Tsai MF, Tsai HR, Chuang LY, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Tsai JF. Urinary transforming growth factor α and serum α-fetoprotein as tumor markers of hepatocellular carcinoma. Tumour Biol 2014;35:3689-98. [PMID: 24375326 DOI: 10.1007/s13277-013-1488-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Hennig M, Yip-Schneider MT, Klein P, Wentz S, Matos JM, Doyle C, Choi J, Wu H, O'Mara A, Menze A, Noble S, McKillop IH, Schmidt CM. Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma. J Surg Res 2009;154:187-95. [PMID: 19321179 DOI: 10.1016/j.jss.2008.11.836] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
15 Lucia Pannain V, Rodrigo Morais J, Damasceno-ribeiro O, Avancini-alves V. Transforming growth factor α immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue. Annals of Hepatology 2012;11:495-9. [DOI: 10.1016/s1665-2681(19)31463-2] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 Moon WS, Park HS, Yu KH, Park MY, Kim KR, Jang KY, Kim JS, Cho BH. Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis. Hum Pathol. 2006;37:1324-1332. [PMID: 16949929 DOI: 10.1016/j.humpath.2006.04.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
17 Garcia-Lezana T, Lopez-Canovas JL, Villanueva A. Signaling pathways in hepatocellular carcinoma. Adv Cancer Res 2021;149:63-101. [PMID: 33579428 DOI: 10.1016/bs.acr.2020.10.002] [Reference Citation Analysis]